SCHEMBL4604806

SCHEMBL4604806

C=Cc1ccc2[nH]cnc(=O)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 1/20 0.38
▸ IP6K1 Q92551 6/20 0.37
▸ IP6K3 Q96PC2 2/20 0.37
▸ IP6K2 Q9UHH9 1/20 0.37
▸ HDAC1 Q13547 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ PRNP P04156 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ CCNB2 O95067 1/20 0.32
▸ CDK1 P06493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5105611 0.85 KIF11 (0.45) IP6K1IP6K3IP6K2HDAC1ALDH1A1
SCHEMBL4236815 0.75 MAPT (0.42) IP6K1IP6K3IP6K2HDAC1ALDH1A1
SCHEMBL1584889 0.75 PIM1 (0.56) ALDH1A1PIM1MEN1KMT2APRNP
SCHEMBL8622177 0.75 ACVR1 (0.46) IP6K1ALDH1A1PIM1MEN1KMT2A
SCHEMBL2191001 0.74 PARP1 (0.54) ALDH1A1PIM1HPGDCHEK1FLT3
SCHEMBL2574527 0.74 LMNA (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL2191063 0.74 PARP1 (0.54) ALDH1A1KMT2AHTTCHEK1
SCHEMBL216175 0.74 PARP1 (0.54) TYMSALDH1A1PIM1MEN1KMT2A
SCHEMBL8700858 0.74 PARP1 (0.54) ALDH1A1MAPTHPGDSMN1; SMN2PNP
SCHEMBL1507612 0.74 PARP1 (0.54) ALDH1A1PIM1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261974-A1 Novel Chemical Compounds DUFFY KEVIN J 2008-10-23 — — US disclosed
EP-1940812-A2 NOVEL CHEMICAL COMPOUNDS SmithKline Beecham Corporation (US) 2008-07-09 — — EP disclosed
WO-2007038331-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261974-A1 Novel Chemical Compounds HIPK3, HIPK1, HIPK4 TYMS 3740/4885IP6K1 490/4885IP6K3 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback